Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock.
Exosomes
HMGB1
Neutrophil extracellular traps
Platelets
Septic shock
miRNAs
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
29 06 2020
29 06 2020
Historique:
received:
02
10
2019
accepted:
09
06
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
26
3
2021
Statut:
epublish
Résumé
Platelets have been demonstrated to be potent activators of neutrophil extracellular trap (NET) formation during sepsis. However, the mediators and molecular pathways involved in human platelet-mediated NET generation remain poorly defined. Circulating plasma exosomes mostly originating from platelets may induce vascular apoptosis and myocardial dysfunction during sepsis; however, their role in NET formation remains unclear. This study aimed to detect whether platelet-derived exosomes could promote NET formation during septic shock and determine the potential mechanisms involved. Polymorphonuclear neutrophils (PMNs) were cocultured with exosomes isolated from the plasma of healthy controls and septic shock patients or the supernatant of human platelets stimulated ex vivo with phosphate buffer saline (PBS) or lipopolysaccharide (LPS). A lethal cecal ligation and puncture (CLP) mouse model was used to mimic sepsis in vivo; then, NET formation and molecular pathways were detected. NET components (dsDNA and MPO-DNA complexes) were significantly increased in response to treatment with septic shock patient-derived exosomes and correlated positively with disease severity and outcome. In the animal CLP model, platelet depletion reduced plasma exosome concentration, NET formation, and lung injury. Mechanistic studies demonstrated that exosomal high-mobility group protein 1 (HMGB1) and/or miR-15b-5p and miR-378a-3p induced NET formation through the Akt/mTOR autophagy pathway. Furthermore, the results suggested that IκB kinase (IKK) controls platelet-derived exosome secretion in septic shock. Platelet-derived exosomes promote excessive NET formation in sepsis and subsequent organ injury. This finding suggests a previously unidentified role of platelet-derived exosomes in sepsis and may lead to new therapeutic approaches.
Sections du résumé
BACKGROUND
Platelets have been demonstrated to be potent activators of neutrophil extracellular trap (NET) formation during sepsis. However, the mediators and molecular pathways involved in human platelet-mediated NET generation remain poorly defined. Circulating plasma exosomes mostly originating from platelets may induce vascular apoptosis and myocardial dysfunction during sepsis; however, their role in NET formation remains unclear. This study aimed to detect whether platelet-derived exosomes could promote NET formation during septic shock and determine the potential mechanisms involved.
METHODS
Polymorphonuclear neutrophils (PMNs) were cocultured with exosomes isolated from the plasma of healthy controls and septic shock patients or the supernatant of human platelets stimulated ex vivo with phosphate buffer saline (PBS) or lipopolysaccharide (LPS). A lethal cecal ligation and puncture (CLP) mouse model was used to mimic sepsis in vivo; then, NET formation and molecular pathways were detected.
RESULTS
NET components (dsDNA and MPO-DNA complexes) were significantly increased in response to treatment with septic shock patient-derived exosomes and correlated positively with disease severity and outcome. In the animal CLP model, platelet depletion reduced plasma exosome concentration, NET formation, and lung injury. Mechanistic studies demonstrated that exosomal high-mobility group protein 1 (HMGB1) and/or miR-15b-5p and miR-378a-3p induced NET formation through the Akt/mTOR autophagy pathway. Furthermore, the results suggested that IκB kinase (IKK) controls platelet-derived exosome secretion in septic shock.
CONCLUSIONS
Platelet-derived exosomes promote excessive NET formation in sepsis and subsequent organ injury. This finding suggests a previously unidentified role of platelet-derived exosomes in sepsis and may lead to new therapeutic approaches.
Identifiants
pubmed: 32600436
doi: 10.1186/s13054-020-03082-3
pii: 10.1186/s13054-020-03082-3
pmc: PMC7322900
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
380Subventions
Organisme : National Natural Science Foundation of China
ID : 81671944
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81974292
Pays : International
Organisme : National Natural Science Foundation of China
ID : 81701935
Pays : International
Organisme : Key Program of Shanghai Committee of Science and Technology
ID : 18411951200
Pays : International
Organisme : Western medicine guide project of Shanghai Committee of Science and Technology
ID : 17411966000
Pays : International
Organisme : Western medicine guide project of Shanghai Committee of Science and Technology
ID : 19411966000
Pays : International
Références
Blood. 2012 Jan 19;119(3):756-66
pubmed: 22031862
Crit Care. 2012 Aug 13;16(4):R151
pubmed: 22889177
J Appl Physiol (1985). 2010 Sep;109(3):758-67
pubmed: 20558756
Oncogene. 2004 Apr 12;23(16):2891-906
pubmed: 15077152
Thromb Haemost. 2000 Dec;84(6):1087-94
pubmed: 11154118
Nat Rev Cardiol. 2019 Mar;16(3):166-179
pubmed: 30429532
J Clin Invest. 2019 Mar 1;129(3):1372-1386
pubmed: 30645204
Aging (Albany NY). 2019 Feb 21;11(4):1089-1109
pubmed: 30787203
Crit Care. 2019 Feb 13;23(1):44
pubmed: 30760290
J Immunol. 2018 Dec 1;201(11):3392-3400
pubmed: 30355788
Front Vet Sci. 2018 Nov 28;5:291
pubmed: 30547040
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10849-E10858
pubmed: 30373812
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Front Immunol. 2016 Jul 06;7:271
pubmed: 27458459
J Thromb Haemost. 2014 Dec;12(12):2074-88
pubmed: 25163512
Cell Res. 2011 Feb;21(2):290-304
pubmed: 21060338
J Leukoc Biol. 2018 Dec;104(6):1159-1171
pubmed: 30088666
Crit Care. 2018 Mar 15;22(1):68
pubmed: 29540208
J Leukoc Biol. 2019 May;105(5):873-880
pubmed: 30512209
J Biol Chem. 2010 Jun 4;285(23):17442-52
pubmed: 20353945
J Leukoc Biol. 2016 Jan;99(1):153-62
pubmed: 26320263
Nat Commun. 2015 Jun 18;6:7321
pubmed: 26084661
Nat Commun. 2017 Jan 09;8:14041
pubmed: 28067230
Immunity. 2018 Oct 16;49(4):740-753.e7
pubmed: 30314759
Am J Physiol Cell Physiol. 2013 Aug 1;305(3):C348-54
pubmed: 23720022
Immunology. 2017 Aug;151(4):417-432
pubmed: 28375544
Biomolecules. 2015 May 04;5(2):702-23
pubmed: 25946076
Cell Death Dis. 2018 May 22;9(6):597
pubmed: 29789550
Sci Transl Med. 2018 Jul 25;10(451):
pubmed: 30045975
J Exp Med. 2014 Oct 20;211(11):2249-63
pubmed: 25288394
Crit Care. 2007;11(6):R120
pubmed: 17996049
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415887
J Clin Invest. 2012 Jul;122(7):2661-71
pubmed: 22684106
Crit Care. 2007;11(5):R107
pubmed: 17894858
J Cell Physiol. 2019 Feb;234(2):1030-1043
pubmed: 30146762
J Cell Biochem. 2013 Mar;114(3):532-40
pubmed: 22961925
Dis Model Mech. 2013 Jul;6(4):1031-42
pubmed: 23649820
Blood. 2013 May 30;121(22):4567-74
pubmed: 23613522
J Immunol. 2012 Sep 15;189(6):2689-95
pubmed: 22956760
J Leukoc Biol. 2018 Dec;104(6):1199-1213
pubmed: 30106500
Theranostics. 2018 Apr 3;8(9):2565-2582
pubmed: 29721099
PLoS One. 2016 Feb 05;11(2):e0148142
pubmed: 26849138
Blood. 2014 Apr 17;123(16):2573-84
pubmed: 24335230
Crit Care Med. 2004 Mar;32(3):818-25
pubmed: 15090968
Cell Death Differ. 2019 Mar;26(3):395-408
pubmed: 30622307
J Clin Invest. 2006 Dec;116(12):3211-9
pubmed: 17143330